PGI2-generation and antithrombotic activity of orally administered defibrotide

R Niada, M Mantovani, G Prino, R Pescador… - Pharmacological …, 1982 - Elsevier
Defibrotide, a polydeoxyribonucleotide extracted from mammalian organs (laboratory code
Fraction P), displays antithrombotic activity after oral administration on different animal …

Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart

P Löbel, K Schrör - Naunyn-Schmiedeberg's Archives of Pharmacology, 1985 - Springer
Defibrotide is a partially depolymerized DNA fraction, having a molecular weight of about
20,000 and possessing antithrombotic and fibrinolytic activities. The present study was …

A novel insight into the mechanism of the antithrombotic action of defibrotide

R Tettamanti, G Bianchi, PA Vitte, G Kato, R Porta… - Life sciences, 1992 - Elsevier
Defibrotide is a polydeoxyribonucleotide sodium salt with antithrombotic properties. These
properties have been attributed to its profibrinolytic activity [increase of tissue plasminogen …

Protective activity of defibrotide against lethal acute myocardial ischemia in the cat

R Niada, R Porta, R Pescador, M Mantovani… - Thrombosis research, 1986 - Elsevier
Defibrotide (D) is a natural polydeoxyribonucleotide from mammalian lungs with
profibrinolytic and antithrombotic activities. D also has PGI 2-stimulating and tissue …

[引用][C] Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug “defibrotide”. A dual mechanism in the control of vascular pathology

P Bacher, G Kindel, JM Walenga, J Fareed - Thrombosis research, 1993 - Elsevier
Varying times after administration of defibrotide/placebo to the rabbit, the entire thoracic
aorta was carefully isolated and dissected, starting as close to the heart as possible. It was …

Defibrotide as a possible anti-ischemic drug.

S Coccheri, M Nazzari - Seminars in thrombosis and hemostasis, 1996 - europepmc.org
Defibrotide is a polydeoxyribonucleotide extracted from mammalian organs (porcine) and
prepared by controlled depolymerization, resulting in a single-stranded deoxyribonucleotide …

Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin

R Niada, M Mantovani, G Prino, R Pescador, F Berti… - Thrombosis …, 1981 - Elsevier
The antithrombotic activity of Fraction P (FP), a polydeoxyribonucleotide extracted from
mammalian organs, was studied in different models of experimental thrombosis. FP displays …

Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat

R Niada, R Porta, R Pescador, M Mantovani… - Thrombosis research, 1985 - Elsevier
We investigated the effects of Defibrotide (D), a natural polydeoxyribonucleotide, on acute
myocardial ischemia (AMI) in anesthetized cats. A permanent ligature was placed around …

Effect of defibrotide on platelet function.

ON Ulutin, S Balkuv-Ulutin, B Bezer-Göker… - … in thrombosis and …, 1996 - europepmc.org
Defibrotide, a polydeoxyribonucleotide, has been found to modulate endothelial cell
function, causing an increase in tissue plasminogen activator (t-PA) levels, a decrease in …

Possible role of defibrotide in endothelial cell protection.

M Corsi, M Parise, G Gaja, ME Ferrero - International journal of …, 1993 - europepmc.org
Defibrotide is a single-stranded DNA fraction obtained from mammalian lung and is able to
increase prostacyclin production by endothelial cells. It has profibrinolytic and antithrombotic …